Treatment of acute myeloid leukemia and myelodysplastic syndrome by low dose arabinosyl cytosine.

Michele Baccarani(University of Bologna), Lorenzo Lodi(University College London), Giovanna Cavazzini(University of Padua), Renato Fanin(University of Udine), P Morassi, Alfonso Zaccaria(University of Bologna), M Florean, Gabriele Pozzato(University of Trieste), L Guarini, Gianpiero Fasola
PubMed
August 16, 1985
Cited by 1

Related Papers

The ExoMol database: Molecular line lists for exoplanet and other hot atmospheres
|Journal of Molecular Spectroscopy|2016|535
Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score
|Blood|2011|497
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia
|Blood|2011|460
Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse
|Blood|2011|402
The 2015 edition of the GEISA spectroscopic database
|Journal of Molecular Spectroscopy|2016|397